Octamer-binding factor 6 (Oct-6/Pou3f1) is induced by interferon and contributes to dsRNA-mediated transcriptional responses

BMC Cell Biology

Volumn 11, Issue , 2010, Pages

  Hofmann, Elisabeth ^a   Reichart, Ursula ^a   Gausterer, Christian ^a,d   Guelly, Christian ^b   Meijer, Dies ^c   Müller, Mathias ^a   Strobl, Birgit ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DOUBLE STRANDED RNA; FOCAL ADHESION KINASE 1; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 6; NUCLEAR PROTEIN; OCTAMER TRANSCRIPTION FACTOR 6; PROTEIN LSM10; PROTEIN SERINE THREONINE KINASE; SERINE THREONINE PROTEIN KINASE 40; STAT1 PROTEIN; UNCLASSIFIED DRUG; SMALL NUCLEAR RIBONUCLEOPROTEIN; STK40 PROTEIN, MOUSE; VIRUS RNA;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FIBROBLAST; MACROPHAGE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MORPHOGENESIS; MOUSE MUTANT; PATHOLOGY; TRANSCRIPTION INITIATION; VIROLOGY;

MURINAE;

ANIMALS; FIBROBLASTS; IMMUNITY, INNATE; INTERFERON-BETA; MACROPHAGES; MICE; MICE, KNOCKOUT; MICROARRAY ANALYSIS; MORPHOGENESIS; OCTAMER TRANSCRIPTION FACTOR-6; PROTEIN-SERINE-THREONINE KINASES; RIBONUCLEOPROTEIN, U7 SMALL NUCLEAR; RNA, DOUBLE-STRANDED; RNA, VIRAL; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; VIRUS DISEASES;

EID: 77955204848     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-61     Document Type: Article

References (69)

1. Krause CD, Pestka S. Historical developments in the research of interferon receptors. Cytokine Growth Factor Rev 2007, 18(5-6):473-482. 10.1016/j.cytogfr.2007.06.009, 17693124.
2. Decker T, Muller M, Stockinger S. The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 2005, 5(9):675-687. 10.1038/nri1684, 16110316.
3. Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007, 282(28):20059-20063. 10.1074/jbc.R700016200, 17502367.
4. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005, 5(5):375-386. 10.1038/nri1604, 15864272.
5. Decker T, Kovarik P, Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 1997, 17(3):121-134. 10.1089/jir.1997.17.121, 9085936.
6. Matsumoto M, Tanaka N, Harada H, Kimura T, Yokochi T, Kitagawa M, Schindler C, Taniguchi T. Activation of the transcription factor ISGF3 by interferon-gamma. Biol Chem 1999, 380(6):699-703. 10.1515/BC.1999.087, 10430035.
7. Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, Jonjic S, Koszinowski U, Hengel H. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med 2005, 201(10):1543-1553. 10.1084/jem.20041401, 2212917, 15883169.
8. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75(2):163-189. 10.1189/jlb.0603252, 14525967.
9. van Boxel-Dezaire AH, Rani MR, Stark GR. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006, 25(3):361-372. 10.1016/j.immuni.2006.08.014, 16979568.
10. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 1998, 95(26):15623-15628. 10.1073/pnas.95.26.15623, 28094, 9861020.
11. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BR. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 2001, 69(6):912-920.
12. Phillips K, Luisi B. The virtuoso of versatility: POU proteins that flex to fit. J Mol Biol 2000, 302(5):1023-1039. 10.1006/jmbi.2000.4107, 11183772.
13. Ryan AK, Rosenfeld MG. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev 1997, 11(10):1207-1225. 10.1101/gad.11.10.1207, 9171367.
14. Scholer HR, Hatzopoulos AK, Balling R, Suzuki N, Gruss P. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J 1989, 8(9):2543-2550. 401252, 2573523.
15. Meijer D, Graus A, Kraay R, Langeveld A, Mulder MP, Grosveld G. The octamer binding factor Oct6: cDNA cloning and expression in early embryonic cells. Nucleic Acids Res 1990, 18(24):7357-7365. 10.1093/nar/18.24.7357, 332873, 1979677.
16. Monuki ES, Weinmaster G, Kuhn R, Lemke G. SCIP: a glial POU domain gene regulated by cyclic AMP. Neuron 1989, 3(6):783-793. 10.1016/0896-6273(89)90247-X, 2561978.
17. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LW, Rosenfeld MG. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 1989, 340(6228):35-41. 10.1038/340035a0, 2739723.
18. Faus I, Hsu HJ, Fuchs E. Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia. Mol Cell Biol 1994, 14(5):3263-3275. 358693, 7909356.
19. Andersen B, Weinberg WC, Rennekampff O, McEvilly RJ, Bermingham JR, Hooshmand F, Vasilyev V, Hansbrough JF, Pittelkow MR, Yuspa SH, et al. Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. Genes Dev 1997, 11(14):1873-1884. 10.1101/gad.11.14.1873, 9242494.
20. Baumeister H, Meyerhof W. The POU domain transcription factor Tst-1 activates somatostatin receptor 1 gene expression in pancreatic beta -cells. J Biol Chem 2000, 275(37):28882-28887. 10.1074/jbc.M002175200, 10866997.
21. Jaegle M, Mandemakers W, Broos L, Zwart R, Karis A, Visser P, Grosveld F, Meijer D. The POU factor Oct-6 and Schwann cell differentiation. Science 1996, 273(5274):507-510. 10.1126/science.273.5274.507, 8662541.
22. Bermingham JR, Scherer SS, O'Connell S, Arroyo E, Kalla KA, Powell FL, Rosenfeld MG. Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev 1996, 10(14):1751-1762. 10.1101/gad.10.14.1751, 8698235.
23. Ghislain J, Charnay P. Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. EMBO Rep 2006, 7(1):52-58. 10.1038/sj.embor.7400573, 1369227, 16311519.
24. Svaren J, Meijer D. The molecular machinery of myelin gene transcription in Schwann cells. Glia 2008, 56(14):1541-1551. 10.1002/glia.20767, 18803322.
25. Ghazvini M, Mandemakers W, Jaegle M, Piirsoo M, Driegen S, Koutsourakis M, Smit X, Grosveld F, Meijer D. A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration. EMBO J 2002, 21(17):4612-4620. 10.1093/emboj/cdf475, 125415, 12198163.
26. Ryu EJ, Wang JY, Le N, Baloh RH, Gustin JA, Schmidt RE, Milbrandt J. Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss. J Neurosci 2007, 27(43):11552-11559. 10.1523/JNEUROSCI.5497-06.2007, 17959798.
27. Schreiber J, Enderich J, Sock E, Schmidt C, Richter-Landsberg C, Wegner M. Redundancy of class III POU proteins in the oligodendrocyte lineage. J Biol Chem 1997, 272(51):32286-32293. 10.1074/jbc.272.51.32286, 9405434.
28. Jensen NA, Pedersen KM, Celis JE, West MJ. Neurological disturbances, premature lethality, and central myelination deficiency in transgenic mice overexpressing the homeo domain transcription factor Oct-6. J Clin Invest 1998, 101(6):1292-1299. 10.1172/JCI1807, 508683, 9502770.
29. Hai M, Muja N, DeVries GH, Quarles RH, Patel PI. Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J Neurosci Res 2002, 69(4):497-508. 10.1002/jnr.10327, 12210843.
30. Dunn TL, Ross IL, Hume DA. Transcription factor Oct-2 is expressed in primary murine macrophages. Blood 1996, 88(10):4072.
31. Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006, 6(9):644-658. 10.1038/nri1900, 16932750.
32. Doyle SL, O'Neill LA. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 2006, 72(9):1102-1113. 10.1016/j.bcp.2006.07.010, 16930560.
33. Takeuchi O, Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008, 20(1):17-22. 10.1016/j.coi.2008.01.002, 18272355.
34. Levy DE, Marie I, Smith E, Prakash A. Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J Interferon Cytokine Res 2002, 22(1):87-93. 10.1089/107999002753452692, 11846979.
35. Sadzak I, Schiff M, Gattermeier I, Glinitzer R, Sauer I, Saalmuller A, Yang E, Schaljo B, Kovarik P. Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain. Proc Natl Acad Sci USA 2008, 105(26):8944-8949. 10.1073/pnas.0801794105, 2435588, 18574148.
36. Baranek C, Sock E, Wegner M. The POU protein Oct-6 is a nucleocytoplasmic shuttling protein. Nucleic Acids Res 2005, 33(19):6277-6286. 10.1093/nar/gki947, 1275591, 16260476.
37. Sock E, Enderich J, Rosenfeld MG, Wegner M. Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6. J Biol Chem 1996, 271(29):17512-17518. 10.1074/jbc.271.29.17512, 8663425.
38. Mesplede T, Island ML, Christeff N, Petek F, Doly J, Navarro S. The POU transcription factor Oct-1 represses virus-induced interferon A gene expression. Mol Cell Biol 2005, 25(19):8717-8731. 10.1128/MCB.25.19.8717-8731.2005, 1265735, 16166650.
39. Mandemakers W, Zwart R, Jaegle M, Walbeehm E, Visser P, Grosveld F, Meijer D. A distal Schwann cell-specific enhancer mediates axonal regulation of the Oct-6 transcription factor during peripheral nerve development and regeneration. EMBO J 2000, 19(12):2992-3003. 10.1093/emboj/19.12.2992, 203354, 10856243.
40. Meijer D. Neuroscience. Went fishing, caught a snake. Science 2009, 325(5946):1353-1354. 10.1126/science.1180103, 19745142.
41. Nickols JC, Valentine W, Kanwal S, Carter BD. Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat Neurosci 2003, 6(2):161-167. 10.1038/nn995, 12514737.
42. Welstead GG, Brambrink T, Jaenisch R. Generating iPS cells from MEFS through forced expression of Sox-2, Oct-4, c-Myc, and Klf4. J Vis Exp 2008, (14). 2582849, 19066578.
43. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463(7288):1035-1041. 10.1038/nature08797, 20107439.
44. Li L, Sun L, Gao F, Jiang J, Yang Y, Li C, Gu J, Wei Z, Yang A, Lu R, et al. Stk40 links the pluripotency factor Oct4 to the Erk/MAPK pathway and controls extraembryonic endoderm differentiation. Proc Natl Acad Sci USA 2010, 107(4):1402-1407. 10.1073/pnas.0905657107, 2824367, 20080709.
45. Huang J, Teng L, Liu T, Li L, Chen D, Li F, Xu LG, Zhai Z, Shu HB. Identification of a novel serine/threonine kinase that inhibits TNF-induced NF-kappaB activation and p53-induced transcription. Biochem Biophys Res Commun 2003, 309(4):774-778. 10.1016/j.bbrc.2003.08.069, 13679039.
46. Pillai RS, Will CL, Luhrmann R, Schumperli D, Muller B. Purified U7 snRNPs lack the Sm proteins D1 and D2 but contain Lsm10, a new 14 kDa Sm D1-like protein. EMBO J 2001, 20(19):5470-5479. 10.1093/emboj/20.19.5470, 125645, 11574479.
47. Yang XC, Torres MP, Marzluff WF, Dominski Z. Three proteins of the U7-specific Sm ring function as the molecular ruler to determine the site of 3'-end processing in mammalian histone pre-mRNA. Mol Cell Biol 2009, 29(15):4045-4056. 10.1128/MCB.00296-09, 2715809, 19470752.
48. Monuki ES, Kuhn R, Lemke G. Repression of the myelin P0 gene by the POU transcription factor SCIP. Mech Dev 1993, 42(1-2):15-32. 10.1016/0925-4773(93)90095-F, 7690239.
49. Remenyi A, Tomilin A, Scholer HR, Wilmanns M. Differential activity by DNA-induced quarternary structures of POU transcription factors. Biochem Pharmacol 2002, 64(5-6):979-984. 10.1016/S0006-2952(02)01164-4, 12213595.
50. Kuhlbrodt K, Herbarth B, Sock E, Enderich J, Hermans-Borgmeyer I, Wegner M. Cooperative function of POU proteins and SOX proteins in glial cells. J Biol Chem 1998, 273(26):16050-16057. 10.1074/jbc.273.26.16050, 9632656.
51. Reiprich S, Kriesch J, Schreiner S, Wegner M. Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells. J Neurochem 2009,
52. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264(5167):1918-1921. 10.1126/science.8009221, 8009221.
53. Karaghiosoff M, Neubauer H, Lassnig C, Kovarik P, Schindler H, Pircher H, McCoy B, Bogdan C, Decker T, Brem G, et al. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 2000, 13(4):549-560. 10.1016/S1074-7613(00)00054-6, 11070173.
54. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996, 84(3):443-450. 10.1016/S0092-8674(00)81289-1, 8608598.
55. Reis LF, Ruffner H, Stark G, Aguet M, Weissmann C. Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J 1994, 13(20):4798-4806. 395418, 7957048.
56. Erlandsson L, Blumenthal R, Eloranta ML, Engel H, Alm G, Weiss S, Leanderson T. Interferon-beta is required for interferon-alpha production in mouse fibroblasts. Curr Biol 1998, 8(4):223-226. 10.1016/S0960-9822(98)70086-7, 9501984.
57. Baccarini M, Bistoni F, Lohmann-Matthes ML. In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells. J Immunol 1985, 134(4):2658-2665.
58. Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 1963, 17:299-313. 10.1083/jcb.17.2.299, 2106200, 13985244.
59. Strobl B, Bubic I, Bruns U, Steinborn R, Lajko R, Kolbe T, Karaghiosoff M, Kalinke U, Jonjic S, Muller M. Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus. J Immunol 2005, 175(6):4000-4008.
60. Zwart R, Broos L, Grosveld G, Meijer D. The restricted expression pattern of the POU factor Oct-6 during early development of the mouse nervous system. Mech Dev 1996, 54(2):185-194. 10.1016/0925-4773(95)00472-6, 8652411.
61. Lillemeier BF, Koster M, Kerr IM. STAT1 from the cell membrane to the DNA. EMBO J 2001, 20(10):2508-2517. 10.1093/emboj/20.10.2508, 125461, 11350940.
62. Jaegle M, Ghazvini M, Mandemakers W, Piirsoo M, Driegen S, Levavasseur F, Raghoenath S, Grosveld F, Meijer D. The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes Dev 2003, 17(11):1380-1391. 10.1101/gad.258203, 196070, 12782656.
63. Ananko EA, Kondrakhin YV, Merkulova TI, Kolchanov NA. Recognition of interferon-inducible sites, promoters, and enhancers. BMC Bioinformatics 2007, 8:56. 10.1186/1471-2105-8-56, 1810324, 17309789.
64. Kovarik P, Stoiber D, Novy M, Decker T. Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J 1998, 17(13):3660-3668. 10.1093/emboj/17.13.3660, 1170702, 9649436.
65. Letertre C, Perelle S, Dilasser F, Arar K, Fach P. Evaluation of the performance of LNA and MGB probes in 5'-nuclease PCR assays. Mol Cell Probes 2003, 17(6):307-311. 10.1016/j.mcp.2003.08.004, 14602482.
66. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001, 25(4):386-401. 10.1006/meth.2001.1261, 11846608.
67. Karaghiosoff M, Steinborn R, Kovarik P, Kriegshauser G, Baccarini M, Donabauer B, Reichart U, Kolbe T, Bogdan C, Leanderson T, et al. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 2003, 4(5):471-477. 10.1038/ni910, 12679810.
68. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4(5):P3. 10.1186/gb-2003-4-5-p3, 12734009.
69. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57. 10.1038/nprot.2008.211, 19131956.